Viking's VK2809 shows positive effect in POC study in glycogen storage disease; shares ahead 10% premarket [Seeking Alpha]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Seeking Alpha
Preliminary results from a proof-of-concept (POC) study assessing Viking Therapeutics' (NASDAQ: VKTX ) VK2809 in an in vivo model of a rare orphan disorder called glycogen storage disease Ia (GSD 1a) showed an encouraging effect. Specifically, treatment with VK2809 produced rapid and substantial reductions in liver triglyceride content (more than 60%) and liver weight (more than 30%) compared to vehicle controls. GSD Ia is characterized by an inability to metabolize glucose precursors which results in low blood sugar and increased metabolic formation of fat. VK2809 is an orally available, tissue and receptor-subtype selective agonist of the thyroid beta receptor. It belongs to a family of novel prodrugs which are cleaved in vivo to release potent thyromimetics. The study is ongoing. Complete results will be presented at an upcoming scientific conference. Shares are up premarket on average volume. Now read: IPO Bumps Slow, But No Need To Panic Yet »
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- 2 Top Biotech Buyout Candidates [Yahoo! Finance]Yahoo! Finance
- Is the stock market open on Good Friday? [Yahoo! Finance]Yahoo! Finance
- Ending 6% commissions could create a ‘Venus flytrap situation' for home buyers, economist says [Yahoo! Finance]Yahoo! Finance
- ‘I was devastated by her infidelity': I'm still on the deed of my ex-wife's house, but our divorce decree says she gets the property. Am I sitting on a golden goose? [Yahoo! Finance]Yahoo! Finance
- 5 Things You Need to Know If You Buy Viking Therapeutics Stock Today [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 2/7/24 - In-Line
VKTX
Sec Filings
- 3/27/24 - Form 4
- 3/27/24 - Form 4
- 3/27/24 - Form 4
- VKTX's page on the SEC website